Parmis, Berwyn A.
HRN: 07 36 09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/27/2024
05/03/2024
IV
600mg
Q8
Cellulitis Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes